Several biological mechanisms were suggested as a possible explanation for potential effects of aspirin and other anti-inflammatory medications on breast cancer risk, including inhibition of COX-2 enzyme activity [7, 13, 14] that mediates the synthesis of prostaglandin E2 (PGE-2) [7]. The gene discussed is PTGS2; the disease is breast carcinoma.